Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Kenny Galvez"'
Autor:
Claudia Lucía Sossa, Virginia Abello, Humberto Martinez, Jheremy Enrique Reyes Castellanos, Guillermo Enrique Quintero Vega, William Armando Mantilla Duran, Kenny Galvez, Rigoberto Gómez Gutierrez, Henry Idrobo Quintero, Carmen Rosales, Mario Ernesto Correa Correa, Paola Andrea Guerrero Burbano, Lina Maria Gaviria Jaramillo, Isabel Munevar, Yazmin Borjas, Luis Antonio Salazar, Angela María Peña, Manuel Rosales, David Martinez-Cuadrón, Pau Montesinos, Manuel Sanz
Publikováno v:
HemaSphere, Vol 7, p e4961422 (2023)
Externí odkaz:
https://doaj.org/article/04b0e43486574cbeaf8c6aff60d9ca15
Autor:
Vania Hungria, Rafael Gaiolla, Kenny Galvez, Guillermina Remaggi, Natalia Schutz, Rosane Bittencourt, Angelo Maiolino, Guillermo Quintero, Maria Silvana Cugliari, Walter Moises Tobias, Carolina Colaco Villarim, Edvan Crusoe, Alicia Ines Enrico, Huiling Pei, Mariana Fernandez, Jaqueline Saes, Damila Trufelli
Publikováno v:
HemaSphere, Vol 7, p e6700375 (2023)
Externí odkaz:
https://doaj.org/article/b29230b15faf453983ce818645174560
Autor:
Rodrigo Abensur Athanazio MD, PhD, José Manuel Ceresetto MD, Luis Javier Marfil Rivera MD, Gabriela Cesarman-Maus MD, PhD, Kenny Galvez MD, Marcos Arêas Marques MD, Aldo Hugo Tabares MD, Carlos Alberto Ortiz Santacruz MD, Fernando Costa Santini MD, Luis Corrales MD, Alexander T. Cohen MBBS, MSc, MD, FRACP, FESC
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Venous thromboembolism (VTE) is a leading cause of morbidity and mortality in patients with cancer. On the basis of results from randomized controlled trials, direct oral anticoagulants (DOACs) are now recommended for the treatment of cancer-associat
Externí odkaz:
https://doaj.org/article/8ab748bf4e814de590a626a9dc9e0e02
Autor:
Virginia Abello, William Armando Mantilla, Henry Idrobo, Claudia Lucia Sossa, Luis Antonio Salazar, Angela Pena, Juan Manuel Herrera, Paola Guerrero, Daniel Espinosa, Guillermo Enrique Quintero-Vega, Isabel Munevar, Kenny Galvez, Alicia Henao, Rigoberto Gómez, Jose Domingo Saavedra, Lina María Gaviria, Mónica Osuna, María Victoria Mateos
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:e405-e413
Multiple Myeloma (MM) is a plasma cell derived clonal disorder that represents around 1% of all newly diagnosed neoplasms. Limited data regarding MM treatment in Latin America is available, and access to novel agents for a substantial portion of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9374b6a912765cf46660af9204098c99
https://doi.org/10.1016/j.clml.2021.12.009
https://doi.org/10.1016/j.clml.2021.12.009
Autor:
Vania T.M. Hungria, Damila Trufelli, Jaqueline Saes, Karina Nakajima, Lays Leonel, Rafael Gaiolla, Kenny Galvez, Guillermina Remaggi, Rosane Bittencourt, Angelo Maiolino, Natalia Paola Schutz, Guillermo Quintero
Publikováno v:
Blood. 140:12487-12489
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81ae73493323cf426b28b19634110b46
https://doi.org/10.1182/blood-2022-163763
https://doi.org/10.1182/blood-2022-163763
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Telma Santos, Fernando Barroso, Luis Palmer, Carmen Cao, Maria Silvana Cugliari, Alicia Enrico, David M. Gómez, Gerardo Machnicki, Carlos E. Miguel, Maria Jose Mela, Mariana Fernandez, Oscar Avendaño Flores, Odin de la Mora, Jorge Armenta, Danielle Leão Cordeiro de Farias, Daniel de Iracema, Celso Arrais, Vania Hungria, Sergio Schusterschitz, Kenny Galvez, Christian Ramos, Laura M. Foggliatto, Gladys Agreda, Lineth Lopez, Jorge Vela, William Mantilla, Rodrigo Santucci, Elena J Tuna-Aguilar, Carolina Pavlovsky, Miguel A. Pavlovsky, Carlos S. Chiattone, Alvaro Gomez, Roberto Ovilla, Claudia Sossa, Deborah Martínez, Lina M. Abenoza, Ana Lisa Basquiera, Paula Barreyro, Guillermina Remaggi
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-19 (2019)
Journal of Global Oncology
Journal of Global Oncology
PURPOSE Limited information is available on multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma (NHL) management in Latin America. The primary objective of the Hemato-Oncology Latin America (HOLA) study was to describe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5534d8248a117781a7f99c2a2bf6a150
https://doi.org/10.1200/jgo.19.00025
https://doi.org/10.1200/jgo.19.00025
Autor:
Jeffrey A. Zonder, Alexandra Jungova, Magda Bařinová, Katja Weisel, Roman Hájek, Evangelos Terpos, Frits van Rhee, Rafat Abonour, Jorge Vela-Ojeda, Michael A. Thompson, Robert M. Rifkin, Jin Lu, Jennifer Elliott, Xavier Leleu, Vladimir Maisnar, Kenny Galvez, Ajai Chari, Faith E. Davies, Lenka Capkova, Jiří Minařík, Caitlin Costello, Lucie Brozova, Jan Straub, Jesus G. Berdeja, Noemi Puig, Hans C. Lee, Kaili Ren, Mario Boccadoro, Jiří Šilar, Saad Z. Usmani, Dawn Marie Stull, Gordon Cook, Matyáš Kuhn, Luděk Pour, Andrew Spencer, Vania Tm Hungria
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
[Aim]: To evaluate the effectiveness and safety of ixazomib-lenalidomide-dexamethasone (IRd) in relapsed/refractory multiple myeloma in routine clinical practice. Patients & methods: Patient-level data from the global, observational INSIGHT MM and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbb2eb25f28b45fad8a319815d33ed8e
http://hdl.handle.net/10261/261619
http://hdl.handle.net/10261/261619
Autor:
Claudia Patricia Casas Patarroyo, Kenny Galvez, Susan Rojas, Claudia Del Pilar Agudelo López, Jimmy Lagos Ibarra, Linda Ibatá Bernal
Publikováno v:
Revista médica de Chile v.147 n.3 2019
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Acquired hemophilia A (AHA) is a rare and life-threatening autoimmune hemorrhagic disorder where autoantibodies are developed against factor VIII. An early diagnosis is challenging and mandatory: an immediate hemostatic control is required to reduce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2648dd55d3d35057281f4300510397b2
https://doi.org/10.4067/s0034-98872019000300334
https://doi.org/10.4067/s0034-98872019000300334
Autor:
Kenny Galvez
Publikováno v:
Innovative Journal of Medical and Health Science. 9:247-251
Bortezomib is a preferred yet costly drug in multiple myeloma (MM) treatment. Thus, despite its benefits, bortezomib is substituted with cheaper options like thalidomide; sometimes compromising the efficacy of treatment. This case report of a 53-year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f5ee3bcbd2ba0271a0a1f74083e0d34
https://doi.org/10.15520/ijmhs.v9i1.2431
https://doi.org/10.15520/ijmhs.v9i1.2431